Differentiation-dependent Expression of I and Sialyl I Antigens in the Developing Lung of Human Embryos and in Lung Cancers

Cancer Research

Volumn 50, Issue 23, 1990, Pages 7603-7611

  Itai, Shigeyuki ^a   Nishikata, Junko ^a   Takahashi, Naofumi ^a   Tanaka, Osamu ^f   Matsubara, Yoshito ^b   Hasegawa, Shizuo ^c   Yanai, Noboru ^d   Takaoka, Kazuo ^e   Arii, Shigeki ^a   Tobe, Takayoshi ^a   Kannagi, Reiji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO KATSURA HOSPITAL   (Japan)

^c University of Tsukuba School of Medicine   (Japan)

^d Nikko Memorial Hospital ^*  (Japan)

^e Nikko Memorial Hospital   (Japan)

^f SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SIALIC ACID;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP LEWIS SYSTEM; CELL DIFFERENTIATION; CONTROLLED STUDY; DEVELOPMENT; EMBRYO; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; ANTIGENS, CD15; EMBRYO; EMBRYO AND FETAL DEVELOPMENT; GENE EXPRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; SUPPORT, NON-U.S. GOV'T;

EID: 0025647989     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Hakomori, S., and Kannagi, R. Glycosphingolipids as tumor-associated and differentiation markers: a guest editorial. J. Natl. Cancer Inst., 71:231–251, 1983.
2. Kannagi, R., and Hakomori, S. Monoclonal antibodies directed to carbohydrate antigens. In: D. M. Weir and L. A. Herzenberg (eds.), Handbook of Experimental Immunology, Vol. 4: Applications of immunological methods in biomedical sciences, pp. 117.1–117.20. Boston: Blackwell Scientific Publishers, Inc., 1986.
3. Hakomori, S. Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Annu. Rev. Biochem., 50: 733–764, 1981.
4. Hakomori, S. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv. Cancer Res., 52: 257–331, 1989.
5. Solter, D., and Knowles, B. B. Monoclonal antibody defining a stage-specific embryonic antigen (SSEA-1). Proc. Natl. Acad. Sci. USA, 75: 5565–5569, 1978.
6. Kannagi, R., Nudelman, E., Levery, S. B., and Hakomori, S. A series of human erythrocyte glycospingolipids reacting to the monoclonal antibody directed to developmentally-regulated antigen, SSEA-1. J. Biol. Chem., 257: 14865–14874, 1982.
7. Kannagi, R., Nudelman, E., and Hakomori, S. Possible role of ceramide in defining the structure and function of membrane glycolipids. Proc. Natl. Acad. Sci. USA, 79: 3470–3474, 1982.
8. Spitalnik, S. L., Spitalnik, P. F., Dubois, C., Mulshine, J., Magnani, J. L., Cuttitta, F., Civin, C. I., Minna, J. D., and Ginsburg, V. Glycolipid antigen expression in human lung cancer. Cancer Res., 46:4751–4755, 1986.
9. Cuttita, F., Rosen, S., Gazdar, A. F., and Minna, J. D. Monoclonal antibodies that demonstrate specificity for several types of human lung cancer. Proc. Natl. Acad. Sci. USA, 78:4591–4595, 1981.
10. Huang, L. C., Brockhaus, M., Magnani, J. L., Cuttitta, S. R., Minna, J. D., and Ginsburg, V. Many monoclonal antibodies with an apparent specificity for certain lung cancers are directed against a sugar sequence found in lacto-N-fucopentaose III. Arch. Biochem. Biophys., 220: 318–320, 1983.
11. Watanabe, K., Hakomori, S., Childs, R. A., and Feizi, T. Characterization of a blood group I-active ganglioside. Structural requirements for I and i specificities. J. Biol. Chem., 254: 3221–3228, 1979.
12. Marsh, W. L. Anti-i: cold antibody defining the Ii relationship in human red cells. Br. J. Haematol., 7: 200–209, 1961.
13. Watanabe, K., and Hakomori, S. Status of blood group carbohydrate chains in ontogenesis and in oncogenesis. J. Exp. Med., 144:644–654, 1976.
14. Hakomori, S. Blood group ABH and Ii antigens of human erythrocytes: chemistry, polymorphism, and their developmental change. Semin. Hematol., 18: 39–62, 1981.
15. Miyake, M., Zenita, K., Tanaka, O., Okada, Y., and Kannagi, R. Stage-specific expression of SSEA-1-related antigens in the developing lung of human embryos and its relation to the distribution of these antigens in lung cancers. Cancer Res., 48: 7150–7158, 1988.
16. Kannagi, R., Fukushi, Y., Tachikawa, T., Noda, A., Shin, S., Shigeta, K., Hiraiwa, N., Fukuda, Y., Inamoto, T., Hakomori, S., and Imura, H. Quantitative and qualitative characterization of cancer-associated serum glycoprotein antigens expressing fucosyl or sialosyl-fucosyl type 2 chain polylactosamine. Cancer Res., 46: 2619–2626, 1986.
17. Zenita, K., Kirihata, Y., Kitahara, A., Shigeta, K., Higuchi, K., Hirahsima, K., Murachi, T., Miyake, M., Takeda, T., and Kannagi, R. Fucosylated type 2 chain polylactosamine antigens in human lung cancer. Int. J. Cancer, 41: 344–349, 1988.
18. Fenderson, B. A., Nichols, E. J. Clausen, H., and Hakomori, S. A monoclonal antibody defining a binary N-acetyllactosaminyl structure in lactoisooctao-sylceramide (IV6Gal β 1→4GlcNAcnLc6): a useful probe for determining differential glycosylation patterns between normal and transformed human fibroblasts. Mol. Immunol., 23: 747–754, 1986.
19. Nudelman, E. D., Mandel, U., Levery, S. B., Kaizu, T., and Hakomori, S. A series of disialogangliosides with binary 2–3 sialosyllactosamine structure, defined by monoclonal antibody NUH2, are oncodevelopmentally regulated antigens. J. Biol. Chem., 264:18719–18725, 1989.
20. Hamilton, W. J., and Mossman, H. W. (eds.). Human Embryology. Prenatal Development of Form and Function. Cambridge, United Kingdom: W. Heffer & Sons Ltd., 1972.
21. Nishimura, H. (ed.). Atlas of Human Prenatal Histology. Tokyo: Igaku-syoin, 1981.
22. Tanaka, O., Oki, M., and Shimatsu, A. Histogenetic study on human fetal lungs. Shimane J. Med. Sci., 4:81–90, 1980.
23. Okada, Y., Kannagi, R., Levery, S. B., and Hakomori, S. Glycolipid antigens with blood group I and i specificities from human adult and cord erythrocytes. J. Immunol., 755:835–842, 1984.
24. Niemann, H., Watanabe, K., Hakomori, S., Childs, R. A., and Feizi, T. Blood group i and I activities of “lacto-jV-nor-hexaosylceramide” and its analogues: the structural requirements for i-specificities. Biochem. Biophys. Res. Commun., 81: 1286–1293, 1978.
25. Fenderson, B. A., Eddy, E. M., and Hakomori, S. The blood group I antigen defined by monoclonal antibody C6 is a marker of early mesoderm during murine embryogenesis. Differentiation, 38:124–133, 1988.
26. Kannagi, R., Hakomoro, S-I., and Imura, H. Cancer-associated serum glycoprotein antigens expressing type 1 and 2 chain polylactosamines. In: S-I. Hakomori, C. Reading, and D. Marcus (eds.), Altered Glycosylation in Tumor Cells, pp. 279–294. New York: Alan R. Liss, Inc., 1988.
27. Itai, S., Arii, S., Tobe, R., Kitahara, A., Kim, Y.-C., Yamabe, H., Ohtsuki, H., Kirihata, Y., Shigeta, K., and Kannagi, R. Significance of 2–3 and 2–6 sialylation of Lewis A antigen in pancreas cancer. Cancer (Phila.), 61: 775–787, 1988.